Regional distribution
For distributors with surgeon relationships and territory depth we don't yet have. You open the region; we supply the category, the training, and the evidence. A defensible product line your competitors can't source.
A partner doesn't have to build the category. The category is built. FDA-cleared. Published. Manufactured. Trained. Distributed. The work of launching the only Type II sinus tarsi stent in the world is behind us — and it's the ground everything ahead stands on.
Adult flatfoot and hyperpronation are among the most common structural conditions in the adult musculoskeletal system. Roughly 2 billion adults worldwide live with a version of this problem — most told to manage it, never to fix it.
We've treated one-twenty-thousandth of it. The market is not a hypothesis. The demand is already there. What's missing is reach.
A partnership is two companies, one category. You bring the market and the commercial team. We bring the science, the pipeline, and twenty years of making a profitable category that didn't exist before — as the educators, the innovators, and the US manufacturer behind it. Value moves both ways.
For distributors with surgeon relationships and territory depth we don't yet have. You open the region; we supply the category, the training, and the evidence. A defensible product line your competitors can't source.
For strategics entering or consolidating the EOTTS category. You bring the scale, sales force, and hospital contracts. We bring an FDA-cleared, patent-protected platform — and skip a decade of build, clinical, and clearance work on both sides.
For foot and ankle brands that want to own a Type II line under their own mark. You bring the brand and the bag; we bring ISO 13485 US manufacturing and the only FDA-cleared device in the category. Your catalog grows; our capacity stays full.
Direct line to our commercial team. Include your region and which path fits. A real person replies, usually within a business day.